Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorHenry M. Jackson Foundation for the Advancement of Military Medicine

About this trial

Adjustment disorders (AjDs) - a group of mental health diagnosis given following exposure to a stressor that results in preoccupation, failure to adapt, and/or functional impairments - have consistently remained the most common mental health diagnoses in the US military across branches for more than a decade. AjDs can be dangerous and negatively affect military readiness by reducing availability of members and through use of resources to allow evacuations from combat. Diagnosing AjDs can be challenging as it is closely related to other well-defined mental health disorders and assessment and research on AjDs have historically been difficult due to the lack of clarity in the disorder's diagnostic criteria. However, the Adjustment Disorder New Module (ADNM-20) is a recently developed instrument that has shown promise.

In previous work, our team adapted the ADNM-20 to the US military population after finding that there was a need for an AjD-specific diagnostic instrument in this population; this instrument is referred to as the ADNM-20-Mil. The principal focus of this study is the longitudinal psychometric validation of the ADNM-20-mil. However, another goal of the proposed study is to pilot test the audio-visual stimulation device SANA for AjD as pilot testing such a device for AjD is a needed next step. Furthermore, the proposed, longitudinal study provides an ideal platform to test the ADNM-20-Mil's sensitivity to change in the context of this pilot trial to address this critical area of need.

Eligibility criteria

Qualifiers

Age 18-64

Serving as active duty in the US Military

Diagnosed with adjustment disorder (with or without depression and/or anxiety) within the last 3 months

No other mental health diagnosis (e.g., schizophrenia spectrum and other psychotic disorders, substance use disorder, bipolar and related disorders, TBI)

Disqualifiers

Significant medical conditions or other circumstances which would preclude compliance with the protocol, adequate cooperation in the study or obtaining informed consent, or may prevent the patient from safely participating in study.

Does not meet the eligibility criteria

Unable to read, speak, or comprehend English

Unable or unwilling to give informed consent

Trial design

Treatments tested in this trial

  • SANA

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Henry M. Jackson Foundation for the Advancement of Military Medicine

Lead sponsor

Uniformed Services University of the Health Sciences

Collaborator